Vita-Salute San Raffaele University, Milan, Italy.
In Vivo Human Molecular and Structural Neuroimaging Unit, Division of Neuroscience, IRCCS San Raffaele Scientific Institute, Milan, Italy.
Eur J Nucl Med Mol Imaging. 2019 May;46(5):1117-1131. doi: 10.1007/s00259-018-4246-2. Epub 2019 Jan 7.
The role for [18F]FDG-PET in supporting amyotrophic lateral sclerosis (ALS) diagnosis is not fully established. In this study, we aim at evaluating [18F]FDG-PET hypo- and hyper-metabolism patterns in spinal- and bulbar-onset ALS cases, at the single-subject level, testing the diagnostic value in discriminating the two conditions, and the correlations with core clinical symptoms severity.
We included 95 probable-ALS patients with [18F]FDG-PET scan and clinical follow-up. [18F]FDG-PET images were analyzed with an optimized voxel-based-SPM method. The resulting single-subject SPM-t maps were used to: (a) assess brain regional hypo- and hyper-metabolism; (b) evaluate the accuracy of regional hypo- and hyper metabolism in discriminating spinal vs. bulbar-onset ALS; (c) perform correlation analysis with motor symptoms severity, as measured by ALS-FRS-R.
Primary motor cortex showed the most frequent hypo-metabolism in both spinal-onset (∼57%) and bulbar-onset (∼64%) ALS; hyper-metabolism was prevalent in the cerebellum in both spinal-onset (∼56.5%) and bulbar-onset (∼55.7%) ALS, and in the occipital cortex in bulbar-onset (∼62.5%) ALS. Regional hypo- and hyper-metabolism yielded a very low accuracy (AUC < 0.63) in discriminating spinal- vs. bulbar-onset ALS, as obtained from single-subject SPM-t-maps. Severity of motor symptoms correlated with hypo-metabolism in sensorimotor cortex in spinal-onset ALS, and with cerebellar hyper-metabolism in bulbar-onset ALS.
The high variability in regional hypo- and hyper-metabolism patterns, likely reflecting the heterogeneous pathology and clinical phenotypes, limits the diagnostic potential of [18F]FDG-PET in discriminating spinal and bulbar onset patients.
18F]FDG-PET 在支持肌萎缩侧索硬化症(ALS)诊断中的作用尚未完全确定。在这项研究中,我们旨在评估[18F]FDG-PET 在脊髓型和延髓型 ALS 病例中的低代谢和高代谢模式,在个体水平上测试其在区分两种情况的诊断价值,并与核心临床症状严重程度的相关性。
我们纳入了 95 例疑似 ALS 患者,进行了[18F]FDG-PET 扫描和临床随访。使用优化的基于体素的 SPM 方法分析[18F]FDG-PET 图像。所得的个体 SPM-t 图用于:(a)评估脑区的低代谢和高代谢;(b)评估区域低代谢和高代谢在区分脊髓型和延髓型 ALS 的准确性;(c)与 ALS-FRS-R 测量的运动症状严重程度进行相关性分析。
初级运动皮层在脊髓型(约 57%)和延髓型(约 64%)ALS 中均显示最常见的低代谢;在脊髓型(约 56.5%)和延髓型(约 55.7%)ALS 中,小脑高代谢,在延髓型 ALS 中,枕叶皮质高代谢(约 62.5%)。从个体 SPM-t 图获得的区域低代谢和高代谢在区分脊髓型和延髓型 ALS 方面的准确性非常低(AUC < 0.63)。运动症状的严重程度与脊髓型 ALS 中感觉运动皮层的低代谢和延髓型 ALS 中小脑的高代谢相关。
区域低代谢和高代谢模式的高度变异性,可能反映了异质性的病理和临床表型,限制了[18F]FDG-PET 在区分脊髓型和延髓型患者的诊断潜力。